Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25178057 | 1.00 | TSHR (0.40) | TSHRCYP3A4MAPTMEN1THRB | |
| SCHEMBL1361238 | 0.87 | ADRB2 (0.35) | TSHRCYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL1361234 | 0.83 | ADRB2 (0.35) | TSHRCYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL2379584 | 0.83 | ADRB2 (0.35) | TSHRCYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL12544435 | 0.81 | ADRB2 (0.33) | TSHRCYP3A4ADRB2ADRB1ADRB3 | |
| SCHEMBL4694513 | 0.80 | — | — | |
| SCHEMBL9781144 | 0.79 | DNM1 (0.36) | TSHRMAPTMEN1THRBHTT | |
| SCHEMBL11707211 | 0.78 | ADRB2 (0.31) | ADRB2ADRB1ADRB3 | |
| SCHEMBL10960558 | 0.77 | ALDH1A1 (0.33) | TSHR | |
| SCHEMBL7548413 | 0.77 | DNM1 (0.33) | TSHRMAPTMEN1THRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570771-B2 | Curing catalyst used for curing of polymer, production method for said curing catalyst, mositure-curable composition, and production method for cured product | NITTO KASEI CO., LTD. (JP) | 2026-03-10 | — | — | US | disclosed |
| US-12516157-B2 | Curing catalyst used for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product | NITTO KASEI CO., LTD. (JP) | 2026-01-06 | — | — | US | disclosed |
| EP-4180482-B1 | MOISTURE-CURABLE COMPOSITION | NITTO KASEI CO LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| EP-4174052-B1 | CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOISTURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT | NITTO KASEI CO LTD (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-12479869-B2 | Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product | NITTO KASEI CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-4174050-B1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO LTD (JP) | 2025-11-19 | — | — | EP | disclosed |
| EP-4174053-B1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO LTD (JP) | 2025-11-19 | — | — | EP | disclosed |
| EP-4174051-B1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO LTD (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-12460051-B2 | Curing catalyst used for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product | NITTO KASEI CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| CN-115461414-B | Curing catalyst for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product | 日东化成株式会社 | 2024-06-25 | — | — | CN | disclosed |
| US-20230357509-A1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230257487-A1 | CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOSITURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| US-20230235125-A1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | NITTO KASEI CO., LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| EP-4180482-A1 | MOISTURE-CURABLE COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2023-05-17 | — | — | EP | disclosed |
| EP-4174053-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | Nitto Kasei Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
| EP-4174052-A1 | CURING CATALYST USED FOR CURING OF POLYMER, PRODUCTION METHOD FOR SAID CURING CATALYST, MOISTURE-CURABLE COMPOSITION, AND PRODUCTION METHOD FOR CURED PRODUCT | Nitto Kasei Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
| EP-4174051-A1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | Nitto Kasei Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
| EP-4174050-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | Nitto Kasei Co., Ltd. (JP) | 2023-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479869-B2 | Curing catalyst used for curing of polymer, method for producing same, moisture-curable composition, and method for producing cured product | KDM2B, SETDB1, ASH2L | TSHR 4502/4885CYP3A4 909/4885MAPT 2607/4885 |
| US-20230234976-A1 | CURING CATALYST USED FOR CURING OF POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | KDM2B, SETDB1, ASH2L | TSHR 4502/4885CYP3A4 909/4885MAPT 2607/4885 |
| US-20230357509-A1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | KDM2B, SETDB1, ASH2L | TSHR 4380/4885CYP3A4 1264/4885MAPT 2495/4885 |
| US-12570771-B2 | Curing catalyst used for curing of polymer, production method for said curing catalyst, mositure-curable composition, and production method for cured product | RPS6KB1, RPS6KA1, RPS6KB2 | TSHR 1594/4885CYP3A4 1283/4885MAPT 3755/4885 |
| US-12460051-B2 | Curing catalyst used for curing polymer, method for producing same, moisture-curable composition, and method for producing cured product | KDM2B, SETDB1, ASH2L | TSHR 4380/4885CYP3A4 1264/4885MAPT 2495/4885 |
| US-20230235125-A1 | CURING CATALYST USED FOR CURING POLYMER, METHOD FOR PRODUCING SAME, MOISTURE-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | SEM1, KDM2B, ASH2L | TSHR 4384/4885CYP3A4 1634/4885MAPT 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.